HYNR-CS-Allo / CoreStem - LARVOL DELTA

Safety Study of HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell Treatment in Amyotrophic Lateral Sclerosis (clinicaltrials.gov) - P1; N=6; Completed; Sponsor: Hanyang University Seoul Hospital; Active, not recruiting ➔ Completed

Clinical • Trial completion

Safety/Efficacy Study of 2nd Cycle Treatment After 6 Months of 1st Cycle HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell Treatment in ALS (clinicaltrials.gov) - P1; N=6; Active, not recruiting; Sponsor: Hanyang University Seoul Hospital; Recruiting ➔ Active, not recruiting; Trial completion date: Dec 2018 ➔ Oct 2021; Trial primary completion date: Nov 2018 ➔ Mar 2019

Clinical • Enrollment closed • Trial completion date • Trial primary completion date